These NKG2C+ cells undergo proliferative expansion during primary CMV infection in transplant patients (40) and in response to CMV-infected fibroblasts (41), IL-12-producing infected monocytes (42), and CMV UL40-derived peptides (38). This evidence concerns the gene KLRC2 and cytomegalovirus infection.